Trial site
University General Hospital of Ioannina
- 102running trials
- 58closed trials
The trials here
What the 160 trials at this site are about, from their registry records.
- Conditions
- COPD15 trials
- Idiopathic pulmonary fibrosis15 trials
- Chronic kidney disease12 trials
- Multiple myeloma12 trials
- Stroke7 trials
- Asthma6 trials
- Familial hypercholesterolaemia6 trials
- Lung cancer5 trials
- Multiple sclerosis5 trials
- Myeloproliferative neoplasms5 trials
- Type 2 diabetes5 trials
- Acute myeloid leukaemia4 trials
- and 36 more
- Phase
- Phase 3117 trials
- Phase 234 trials
- Phase 2/35 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed56 trials
- Recruiting46 trials
- Active, not recruiting41 trials
- Not yet recruiting15 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca13 trials
- Sanofi7 trials
- Boehringer Ingelheim6 trials
- Janssen Research & Development, LLC6 trials
- Bayer5 trials
- and 75 more
Running trials
Not yet recruiting
Not yet recruiting
A study to compare heart failure medicines in one combined pill with usual care.
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Recruiting
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Showing 50 of 102.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma7 recruiting
- Chronic kidney disease6 recruiting
- COPD4 recruiting
- Idiopathic pulmonary fibrosis4 recruiting
- Type 2 diabetes3 recruiting
- Acute myeloid leukaemia2 recruiting
- Alzheimer disease2 recruiting
- Asthma2 recruiting
- Follicular lymphoma2 recruiting
- Heart failure2 recruiting
- High blood pressure2 recruiting
- Multiple sclerosis2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Atrial fibrillation1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Depression1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Epilepsy1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Glaucoma1 recruiting
- Hodgkin lymphoma1 recruiting
- IgA nephropathy1 recruiting
- Lung cancer1 recruiting
- Macular degeneration1 recruiting
- Metastatic breast cancer1 recruiting
- Peripheral artery disease1 recruiting
- Sickle cell disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thalassaemia1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Non-inferiority study between two formulations Brimonidine 0.2%/Timolol 0.5% eye drops solution
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Completed
Completed
Completed
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Active, not recruiting
Completed
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Completed
Completed
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Completed
Active, not recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Showing 50 of 58.
Site data: ClinicalTrials.govUpdated 19 Nov 2026